PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcgastBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Gastroenterology
 
BMC Gastroenterol. 2017; 17: 48.
Published online 2017 April 8. doi:  10.1186/s12876-017-0601-1
PMCID: PMC5385047

Costs and quality of life of small-incision open cholecystectomy and laparoscopic cholecystectomy - an expertise-based randomised controlled trial

Abstract

Background

Health care providers need solid evidence based data on cost differences between alternative surgical procedures for common surgical disorders. We aimed to compare small-incision open cholecystectomy (SIOC) and laparoscopic cholecystectomy (LC) concerning costs and health-related quality of life using data from an expertise-based randomised controlled trial.

Methods

Patients scheduled for cholecystectomy were assigned to undergo LC or SIOC performed by surgeons in two different expert groups. Total costs were calculated in USD. Reusable instruments were assumed for the cost analysis. Quality of life was measured using the EuroQol 5-D 3-L (EQ 5-D-3L), at five postoperative time points and calculated to Area Under Curve (AUC) for 1 year postoperatively. Two hospitals participated in the trial, which included both emergency and elective surgery.

Results

Of 477 patients that underwent a cholecystectomy during the study period, 355 (74.9%) were randomised and 323 analysed, 172 LC and 151 SIOC patients. Both direct and total costs were less for SIOC than for LC patients. The total costs were 5429 (4293–6932) USD for LC and 4636 (3905–5746) USD for SIOC, P = 0.001. The quality of life index did not differ between the LC and SIOC groups at any time. Median values (25th and 75th percentiles (p25-p75)) for AUC at 1 year were as follows: 349 (337–351) for LC and 349 (338–350) for SIOC.

Conclusions

In this expertise-based randomised controlled trial LC was a more costly procedure and quality of life did not differ after SIOC and LC. (ClinicalTrials.gov Identifier: NCT00370344, August 30, 2006).

Electronic supplementary material

The online version of this article (doi:10.1186/s12876-017-0601-1) contains supplementary material, which is available to authorized users.

Keywords: Minilaparotomy, Health care costs, Surgical procedures

Background

Over the past three decades, there has been substantial development in cholecystectomy techniques, as well as in the pre- and post-operative management of patients. The open surgical procedure with a large incision (OC) [1] has been succeeded by small incision open cholecystectomy (SIOC) [2, 3], laparoscopic cholecystectomy [4], single port laparoscopic cholecystectomy technique [5, 6], robotic cholecystectomy [7], and single port robotic cholecystectomy [8]. It is essential to scrutinise such changes in surgical technology in terms of cost and quality of life, to ensure fair distribution of resources. A meta-analysis of earlier randomised controlled trials showed no statistically significant differences, in terms of postoperative clinical outcomes, between SIOC and LC, but a significantly shorter operating time for SIOC [9]. Similar findings were reported in an expertise-based randomised controlled trial [10]. The aim of the present study is to compare LC and SIOC concerning costs and quality of life assessed by the EuroQol-5D-3L [11] using data from this expertise-based randomised controlled trial [12].

Methods

Details concerning surgical teams and surgical techniques including intra-operative cholangiogram have been described earlier [10]. Primary outcomes were costs and health related quality of life, reported in the current paper, and pain. Secondary outcomes were complications within 30 days, operative time, length of hospital stay, conversion rate, frequency of ambulatory surgery and readmissions within 30 days, which together with pain have been reported earlier [10]. In short, SIOC was performed via a transverse incision over the right rectus muscle and laparoscopic cholecystectomy with a four-trocar technique. If the SIOC incision exceeded 8 cm, the operation was classified as an open cholecystectomy as this was the cut-off in the Swedish registry for gallstone surgery (GallRiks) [13]. Two hospitals participated in the trial, Umeå University Hospital and Lycksele County Hospital. The study was designed as a randomised pragmatic expertise-based trial [12, 14], where participating surgeons were asked to join one of two teams, performing either SIOC or LC, according to their personal preferences. Team members performed their specific method (SIOC or LC) as a first-choice operation, but converted to OC when necessary, and even began the operation using OC when neither LC nor SIOC were considered possible.

Patients

Eligible patients were asked to enrol in the trial at the time when cholecystectomy was decided. Written informed consent was obtained before randomisation. The trial was not blinded.

Inclusion and exclusion criteria

Patients aged 18 years or older with biliary disease where cholecystectomy was considered the best treatment according to published recommendations [15, 16] were asked to participate in the trial. Both elective and emergency patients were enrolled. Patients with acute cholecystitis, choledocholithiasis, jaundice, pancreatitis, obesity and co-morbidity were included if cholecystectomy was considered the best treatment. The exclusion criteria were: inability to understand given information, surgeons from either the LC team or the SIOC team unavailable for emergency cholecystectomy, cholecystectomy performed for malignant disease or suspicion of malignancy, and cholecystectomy performed as part of another operation.

Randomisation

Randomisation was made using an internet-based system with computer-generated random numbers. Patients were automatically stratified at three levels: hospital, age (< or > = 70 years), and degree of priority (elective, emergent, or surgery for life-threatening disease). The patients were randomised when the decision for surgery was made.

Economic analysis

The economic analysis was conducted from a societal perspective, calculating both direct public healthcare costs and indirect costs generated by the loss of productivity (sick leave). Cost generating posts in health care were calculated from the time the patient was admitted for surgery. Preoperative investigations (preoperative radiology, preoperative visits to outpatient clinic, etc.) were not included. Costs for pre-, intra-, and postoperative endoscopic retrograde cholangiogram (ERC), sphincterotomy and endoscopic stone extraction were regarded as a part of the operative procedure and were thus included. Detailed calculations of cost items were performed in one hospital (Umeå University Hospital). All costs are given as USD. Where reliable item costs could be found, they were retrieved from the Hospital Department of Economics (costs for perioperative and secondary cholangiogram, in hospital stay, postoperative recovery unit). Other costs were calculated manually, (disposables, reusable instruments, including laparoscopic equipment). Costs for LC were calculated with the presumption of reusable trocars. Personnel costs per minute were calculated using mean wages for each category of personnel obtained from the Department of Economics, Umeå University Hospital. Costs for social benefits and employer fees, at a rate of 43.71% (mean for hospital staff), were added to the mean wages. Operational costs were calculated with one resident and one senior surgeon participating from incision to last stich for each operation. A standard cost for counselling and administration (hospital record, sick leave certificate and prescription of drugs) were added. The cost for surgical theatre staff was calculated from the moment patients arrived at the theatre until they left for the recovery unit, individually for each patient. All patients were estimated to spend 4 h in the postoperative recovery unit. Patients undergoing ambulatory surgery were estimated to spend 8 h in the surgical ward. An average cost for ERC, sphincterotomy and endoscopic stone extraction of 1216 USD, was estimated by the Hospital Department of Economics. Indirect costs due to loss of production were calculated based on mean wages obtained from Statistics Sweden (SCB) for men and women, respectively, including social benefits and employer fees at a rate of 41.15% (mean for all employed). Indirect costs were calculated only for patients that reported taking a sick leave from work due to the operation. Cost-generating posts are listed in Table 1.

Table 1
Cost-generating items and unit costs

Health-related quality of life

Health-related quality of life was assessed using the EQ 5-D-3L (EuroQol Group, Rotterdam, The Netherlands [11]) which consists of five questions concerning patient mobility, self-care, usual activities, pain/discomfort and anxiety/depression. In this study, a value set derived from the Swedish population was used [17]. The EQ-5D-3L index values were further calculated to AUC and quality adjusted life years (QALYs), please see Sample size, analysis and statistics.

Data collection

The operating surgeon registered the operative data (except for operative time) in the Swedish registry for gallstone surgery, GallRiks [13]. An independent assessor, as defined by GallRiks, registered operative time, length of hospital stay and complications within 30 days. Complications were graded according to Dindo-Clavien [18]. Health-related QoL was recorded by the patient before surgery and on postoperative days 3, 7, 11, and 30, as well as 1 year after surgery. The patient reported length of sick leave at 30 days. Data from GallRiks were controlled against patient hospital records for all patients. Where registration errors were detected, they were corrected.

Sample size, analysis and statistics

The power calculation to determine the sample size for the trial was based on earlier publications on cholecystectomies where the main differentiating factor between the two interventions was duration of the operation. It was assumed that SIOC would take 16 min less compared to LC, based on three previous studies [1921]. The calculation was made for 90% power, 5% significance level and an anticipated data loss of 25%. With these assumptions, it was calculated that the study should consist of at least 350 patients. The sample size was estimated to be sufficient for detecting significant differences of routine costs, but not for comparing relatively rare complications between groups. All analyses were made with the intention-to-treat principle. Quantitative results were presented as median values, 25 and 75th percentiles whenever the distribution of the data was skewed. A non-parametric Mann-Whitney U test was used for statistical tests of significance. AUC (Area Under Curve) values up to 1 year were calculated using the EQ-5D-3L scores at five different postoperative time points and the assumption that the change between time points was linear. Missing EQ-5D-3L values were imputated if the case had at least two registered genuine EQ-5D-3L values at different time points, otherwise the case was excluded from AUC calculation. We used the principle to add (or subtract) the mean change between specific time points for the group (LC or SIOC) to the last genuine value to generate the value for the next time point if it was missing. In all, 128 imputations for missing values were added to the 1372 genuine values. Thirty-three cases were excluded because of more than three missing EQ-5D-3L scores. The EQ-5D-3L scores and AUC values were calculated from raw data using Microsoft® Excel for Mac version 14.2.3 (Microsoft Corporation, Redmond, Washington, USA), and Stata® software release 13.1 (StataCorp LP, College Station, Texas, USA) was used for statistical calculations.

Results

A flow diagram describing the progress from enrolment to analysis according to the CONSORT statement [22] is presented in Fig. 1. Of 477 assessed patients, 355 (74.9%) were randomised. Twenty-two patients (LC 6 and SIOC 16) were excluded from analysis of which 18 declined surgery, two were operated on at a non-participating hospital and 2 were operated on for other non-related disease. Finally 333 were analysed, 177 LC and 156 SIOC patients. Of these 333 patients, postoperative QoL data was available and analysed for 290, 156 LC and 134 SIOC patients. Study protocol violations were noted for 33 patients. In accordance with the CONSORT Statement [22] cases with protocol violations were not excluded, but were analysed according to the original randomisation.

Fig. 1
CONSORT diagram for the trial. Analysis according to the ‘intention to treat’ principle. (Modified reprint from Br J Surg 2013;100(7): 886–894, with written permission from original publisher John Wiley and Sons)

Baseline data

Age, sex, preoperative EQ-5D-3L score, proportion of smokers, proportion employed and education level were similar between the groups (Table 2). The SIOC-group had a longer time between decision for surgery and operation [10], 156 versus 103 days, respectively (P = 0.03), slightly more emergency admissions, and more cases with acute cholecystitis than the LC group, 25.6 and 14.7%, respectively (p = 0.012).

Table 2
Patient characteristics for 333 patients

Outcomes

The median value for direct cost was (p25-p75) 4210 USD (3851–5073) for the LC group and 3963 USD (3512–4848) for the SIOC group, P = 0.002. Operation costs and total costs, including indirect costs, were significantly higher for the LC group, p = <0.001 and p = 0.003 respectively (Table 3).

Table 3
Cholecystectomy costs for all patients

EQ-5D-3L-AUC within 1 year was, median, (p25-p75) 349 (337–351) for the LC group and 349 (338–350) for the SIOC group, P = 0.8096. QALYs had a median of 0.9639 (0.9313–0.9683) and 0.9636 (0.9343–0.9679) in the LC group and SIOC group, respectively. EQ-5D-3L-AUC at 30 days was, median (p25-p75) 25.17 (23.70–25.85) for the LC group and 25.10 (23.67–25.76) for the SIOC group. Index values for EQ-5D-3L at all time points are shown in Fig. 2. Subgroup analyses for costs and QoL of patients that had emergency cholecystectomy, elective cholecystectomy, complications and no complications are presented in Additional file 1: Table S1.

Fig. 2
Health-related quality of life (QoL) scores before operation and at five postoperative time points, measured with the EQ-5D-3L scale, with scores ranging from 0 to 1, where 1 is the best possible health-related quality of life. Values are presented as ...

Discussion

In this expertise - based RCT, LC carried significantly higher costs than SIOC, direct as well as indirect costs but there were no significant differences in health-related QoL between the LC and SIOC group when measured with EQ-5D-3L.

In accordance with previous studies [9], the present trial has not demonstrated significant differences in complication rate between LC and SIOC [10]. It was designed as a pragmatic randomised expertise-based trial [14] with the intention to minimise exclusions and differential bias [12, 14]. The expertise-based setting made it possible to include patients otherwise unfit to be included in a regular trial such as patients with prior upper gastro-intestinal surgery, patients with mild biliary pancreatitis, and patients with acute cholecystitis. Therefore, we had a high percentage of patients assessed for cholecystectomy included in the trial (75%). Operating times in the present study were longer for LC than for SIOC in accordance with previous studies [9]. Our operating times were long reflecting the high inclusion ratio with the ambition to include also acute operations. A setting with disposable trocars and clip applier would have added an estimated 304 USD to the perioperative costs for the LC group.

There are some potential limitations to this study. First, after completion of the study we found that time from randomisation to cholecystectomy was longer for SIOC than for LC patients [10]. We had fewer SIOC surgeons than LC surgeons, 6 vs 11. This increased the time on waiting list for SIOC patients, some of which had to be operated emergently. Consequently, more patients with acute cholecystitis appeared in the SIOC group, which explains the slightly higher pain score and VAS-QoL score preoperatively for SIOC patients [10]. However, in the present report only the validated EQ-5D-3L instrument was utilised for quality of life estimation. Second, measuring indirect costs (e.g. sick leave) can be considered controversial, as it may reflect local traditions as well as political and cultural differences. In Sweden, a doctor’s certificate is required after the seventh’ day of sick leave. The study protocol stated that sick leave certificates should not routinely be written after uncomplicated surgery. In this study, LC patients had a higher cost for loss of production (indirect costs) without QoL difference. This might reflect that surgeons in the SIOC group, after the SIOC training phase were more compliant to the study protocol than the LC group surgeons. This imbalance in sick leave was also found in an earlier study [23].

Several reasons necessitate a discussion of cost-effectiveness in treatment of gallstone disease. The increasing population age in industrialized countries escalates health care costs [24]. Sphincterotomy has separated treatment of bile duct stones and gallbladder stones [25, 26], although SIOC, with choledochotomy, and primary closure of the common bile duct during cholecystectomy is safe, effective and inexpensive when performed by trained surgeons [27]. The decline in training in open surgery for residents [28] is of concern for the treatment of gallstone disease [29, 30]. After appropriate training, SIOC is an alternative to LC wherever the health-care budget is limited, not only in the third world [31].

Conclusions

From this trial we conclude that LC is more costly, but SIOC and LC are comparable in terms of QoL.

Acknowledgments

We acknowledge Health-Economist professor Lars Lindholm at the Department of Public Health and Clinical Medicine, Umeå University for the valuable advice regarding the principles and calculations of QoL and costs. We also thank consultant surgeon Kent Seale, MD for teaching and supervising the SIOC technique during the training phase of the SIOC team, nurses Lena Ivebo, Elisabeth Altin and Astrid Henriksson for registering the study data and information given to patients about the study, and secretary Birgitta Eriksson for registering the follow-up case report forms. Finally, we thank former head of the surgical department, Anders Sylvan, MD, for encouraging the execution of the study.

Funding

Umeå University and the County Council of Västerbotten provided the financial support for this study.

Availability of data and materials

In our approval from the Regional Ethical Review Board of Umeå University, permission to publish results was only approved on statistical group level, not individual results. Therefore raw data on individual level cannot be published. However, by request from individual researchers, the dataset can be provided if the above restrictions can be met.

Authors’ contributions

MHR drafted the manuscript, collected and analysed the data and participated in the design of the study. EN conceived the study, designed the study and participated in the analysis of data and drafting of the manuscript. FL collected and analysed the data and participated in the design of the study. SOÅ collected the economical data and participated in the economical analysis. MMH participated in the design and coordination of the study, performed the statistical analyses and helped to draft the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable. Consent for publication was obtained only on group level and no individual data that could identify a patient is published.

Ethics approval and consent to participate

Approval from the Regional Ethical Review Board of Umeå University was obtained in January 2006 (registration number 05-147M). Written informed consent was obtained before randomisation.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations

AUC
Area under curve
EQ 5-D-3L
EuroQol 5-D 3-L
ERC
Endoscopic retrograde cholangiogram
GallRiks
Swedish registry for gallstone surgery
LC
Laparoscopic cholecystectomy
OC
Open cholecystectomy
QALYs
Quality adjusted life years
SCB
Statistics Sweden
SIOC
Small-incision open cholecystectomy
USD
United States Dollar

Additional file

Additional file 1: Table S1.(19K, docx)

Subgroup analyses. Additional file holds a supplementary table (Table S1) with subgroup cost and QoL analysis of patients that had a) emergency cholecystectomy, b) elective cholecystectomy, c) complications and d) no complications. (DOCX 18 kb)

Contributor Information

Mats H. Rosenmüller, Phone: +46-76-7748600, es.umu.yregrus@rellumnesor.stam.

Erik Nilsson, es.umu@nosslin.kire.

Fredrik Lindberg, es.llv@grebdnil.kirderf.

Sten-Olof Åberg, es.llv@greba.folonets.

Markku M. Haapamäki, es.umu.yregrus@ikamapaah.ukkram.

References

1. Langenbuch C. Ein fall von Exstirpation der Gallenblase wegen chronischer Cholelithiasis. Berlin Klin Wochenschr. 1882;48:725–7.
2. Dubois F, Berthelot B. Cholecystectomy through minimal incision. Nouv Presse Med. 1982;11(15):1139–1141. [PubMed]
3. Seale AK, Ledet WP., Jr Minicholecystectomy: a safe, cost-effective day surgery procedure. Arch Surg. 1999;134(3):308–10. doi: 10.1001/archsurg.134.3.308. [PubMed] [Cross Ref]
4. NIH Consensus conference. Gallstones and laparoscopic cholecystectomy. JAMA. 1993;269(8):1018-1024. [PubMed]
5. Trastulli S, Cirocchi R, Desiderio J, Guarino S, Santoro A, Parisi A, Noya G, Boselli C. Systematic review and meta-analysis of randomized clinical trials comparing single-incision versus conventional laparoscopic cholecystectomy. Br J Surg. 2013;100(2):191–208. doi: 10.1002/bjs.8937. [PubMed] [Cross Ref]
6. Zapf M, Yetasook A, Leung D, Salabat R, Denham W, Barrera E, Butt Z, Carbray J, Du H, Wang CE, et al. Single-incision results in similar pain and quality of life scores compared with multi-incision laparoscopic cholecystectomy: a blinded prospective randomized trial of 100 patients. Surgery. 2013;154(4):662–70. doi: 10.1016/j.surg.2013.04.043. [PubMed] [Cross Ref]
7. Vidovszky TJ, Smith W, Ghosh J, Ali MR. Robotic cholecystectomy: learning curve, advantages, and limitations. J Surg Res. 2006;136(2):172–8. doi: 10.1016/j.jss.2006.03.021. [PubMed] [Cross Ref]
8. Joseph RA, Goh AC, Cuevas SP, Donovan MA, Kauffman MG, Salas NA, Miles B, Bass BL, Dunkin BJ. “Chopstick” surgery: a novel technique improves surgeon performance and eliminates arm collision in robotic single-incision laparoscopic surgery. Surg Endosc. 2010;24(6):1331–5. doi: 10.1007/s00464-009-0769-8. [PubMed] [Cross Ref]
9. Keus F, Gooszen HG, van Laarhoven CJ. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev. 2010;1:CD008318. [PubMed]
10. Rosenmuller MH, Thoren Ornberg M, Myrnas T, Lundberg O, Nilsson E, Haapamaki MM. Expertise-based randomized clinical trial of laparoscopic versus small-incision open cholecystectomy. Br J Surg. 2013;100(7):886–94. doi: 10.1002/bjs.9133. [PubMed] [Cross Ref]
11. The EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi: 10.1016/0168-8510(90)90421-9. [PubMed] [Cross Ref]
12. Vanderlinden W. Pitfalls in randomized surgical trials. Surgery. 1980;87(3):258–62. [PubMed]
13. Enochsson L, Thulin A, Osterberg J, Sandblom G, Persson G. The Swedish Registry of Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks): A nationwide registry for quality assurance of gallstone surgery. JAMA Surg. 2013;148(5):471–8. doi: 10.1001/jamasurg.2013.1221. [PubMed] [Cross Ref]
14. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, Sackett DL, Cina CS, Walter SD, Haynes B, et al. Need for expertise based randomised controlled trials. BMJ. 2005;330(7482):88–91. doi: 10.1136/bmj.330.7482.88. [PMC free article] [PubMed] [Cross Ref]
15. Berhane T, Vetrhus M, Hausken T, Olafsson S, Sondenaa K. Pain attacks in non-complicated and complicated gallstone disease have a characteristic pattern and are accompanied by dyspepsia in most patients: the results of a prospective study. Scand J Gastroenterol. 2006;41(1):93–101. doi: 10.1080/00365520510023990. [PubMed] [Cross Ref]
16. Jørgensen T. Treatment of gallstone patients. Copenhagen: National institute of public health, Danish institute for Health Technology Assessment; 2000.
17. Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–42. doi: 10.1007/s11136-013-0496-4. [PMC free article] [PubMed] [Cross Ref]
18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. doi: 10.1097/01.sla.0000133083.54934.ae. [PubMed] [Cross Ref]
19. Wallace DH, McMahon AJ, O’Dwyer PJ. Randomized trial of laparoscopic cholecystectomy and mini-cholecystectomy. Br J Surg. 1996;83(2):279–80. [PubMed]
20. Majeed AW, Troy G, Nicholl JP, Smythe A, Reed MW, Stoddard CJ, Peacock J, Johnson AG. Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet. 1996;347(9007):989–94. doi: 10.1016/S0140-6736(96)90143-9. [PubMed] [Cross Ref]
21. Ros A, Gustafsson L, Krook H, Nordgren CE, Thorell A, Wallin G, Nilsson E. Laparoscopic cholecystectomy versus mini-laparotomy cholecystectomy: a prospective, randomized, single-blind study. Ann Surg. 2001;234(6):741–9. doi: 10.1097/00000658-200112000-00005. [PubMed] [Cross Ref]
22. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol. 2010;115(5):1063–70. doi: 10.1097/AOG.0b013e3181d9d421. [PubMed] [Cross Ref]
23. Keus F, de Jonge T, Gooszen HG, Buskens E, van Laarhoven CJ. Cost-minimization analysis in a blind randomized trial on small-incision versus laparoscopic cholecystectomy from a societal perspective: sick leave outweighs efforts in hospital savings. Trials. 2009;10:80. doi: 10.1186/1745-6215-10-80. [PMC free article] [PubMed] [Cross Ref]
24. Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg. 2003;238(2):170–7. [PubMed]
25. Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72(4):808–16. doi: 10.1016/j.gie.2010.06.033. [PubMed] [Cross Ref]
26. Sandzen B, Haapamaki MM, Nilsson E, Stenlund HC, Oman M. Treatment of common bile duct stones in Sweden 1989-2006: an observational nationwide study of a paradigm shift. World J Surg. 2012;36(9):2146–53. doi: 10.1007/s00268-012-1648-3. [PubMed] [Cross Ref]
27. Seale AK, Ledet WP., Jr Primary common bile duct closure. Arch Surg. 1999;134(1):22–4. doi: 10.1001/archsurg.134.1.22. [PubMed] [Cross Ref]
28. Chung RS, Ahmed N. The impact of minimally invasive surgery on residents’ open operative experience: analysis of two decades of national data. Ann Surg. 2010;251(2):205–12. doi: 10.1097/SLA.0b013e3181c1b18e. [PubMed] [Cross Ref]
29. Jenkins PJ, Paterson HM, Parks RW, Garden OJ. Open cholecystectomy in the laparoscopic era. Br J Surg. 2007;94(11):1382–5. doi: 10.1002/bjs.5854. [PubMed] [Cross Ref]
30. Livingston EH, Rege RV. Technical complications are rising as common duct exploration is becoming rare. J Am Coll Surg. 2005;201(3):426–33. doi: 10.1016/j.jamcollsurg.2005.04.029. [PubMed] [Cross Ref]
31. Sharma AK, Rangan HK, Choubey RP. Mini-lap cholecystectomy: a viable alternative to laparoscopic cholecystectomy for the Third World? Aust N Z J Surg. 1998;68(11):774–7. doi: 10.1111/j.1445-2197.1998.tb04674.x. [PubMed] [Cross Ref]

Articles from BMC Gastroenterology are provided here courtesy of BioMed Central